Sample IP Agreements

In This Section

Here we maintain a collection of sample agreements relating to intellectual property transactions. Each agreement is annotated to explain the impact of specific provisions contained in the sample agreements. Please note that these agreements are exemplary; a sample agreement included here may not be ideal for every situation. Use them at your own risk.*

You can use the sample agreements in several ways:

Go to the IP Agreement Summaries page (Login Required) to see a brief summary of each sample agreement, and to access the sample agreements (Word format). This page is useful if you are looking for examples of specific agreements (e.g., "I am trying to craft a material transfer agreement, and I want to see an example.")
Go to the Index of Provisions page (Login Required) to see a searchable index of agreement provisions. This page is useful if you are looking for examples of specific agreement provisions (e.g., "I am trying to craft an indemnity provision, and I want to see examples from various agreements.")

* Nothing included in the sample agreements or elsewhere on this site should be considered legal advice on the part of AIPLA or any of its members.

Credits

Up to 180 Minutes Pending

Registration

Fee: Members Only: $125 for Both Days or $99 for Individual Days

Register Now

Join us for this Members Only 2-Day CLE Webinar Series presented by the Chemical Practice and Biotechnology Committees. Following the resounding success of the Chemical Practice and Biotechnology Committees’ joint program at the 2024 AIPLA Spring Meeting in Austin, AIPLA and the Committees will host a two-day program where world-class experts will dive into some of the latest developments in chemical and biotech patent practice.

Day 1 Highlights:

Key Case Analysis: Explore the implications of Sonos v. Google for chemical and biotech practitioners.
In-Depth Discussions: Gain insights on polymorphs in both US and EP practice and the nuances of Orange Book listings in light of Teva v. Amneal.

Day 2 Highlights:

Future Insights: Discover what to expect from the new administration.
In-Depth Discussion: Understand the complexities of claiming numerical ranges in both US and EP practice.
Key Case Analysis: Explore the implications of In re Chamberlain for chemical and biotech practitioners.

Don’t miss this opportunity to engage with industry leaders and stay ahead in the ever-evolving landscape of chemical and biotech patent practice.

Presented by:

Day 1: April 2, 2025 – 12:00 Noon - 1:30pm Eastern

Moderator: Ali Anoff, Procter & Gamble

Speakers: Michelle O’Brien, The Marbury Law Group, Adam Lacy, Hoffmann Eitle, Andrew Wasson, Haug Partners, & Jason Murata, Axinn, Veltrop & Harkrider LLP

Day 2: April 3, 2025 – 12:00 Noon - 1:30pm Eastern

Moderator: Tom Irving, The Marbury Law Group

Speakers: Mary Till, Finnegan Henderson Farabow Garrett & Dunner, Stepehn Kunin, Maier & Maier, Roy Issac, Bristol Myers Squibb, Greg Stepney, Withers & Rogers, & Joanna Brougher, BioPharma Law Group

Registration Fees:

AIPLA Members: $125 for both days or $99 per day

This event is free to AIPLA members who are not requesting CLE. Select "Registrant_No_CLE" during registration.

To register for individual days use the links below:

Register for Day 1 Only

Register for Day 2 Only

To register for BOTH days use the orange "Register Now" button above.

Registration includes:

CLE certification/processing for applicable states. Reference CLE Information below for complete details.
Webinar materials, including complete CLE processing information, accessible 24-48 hours before webinar date.

Cancellation Policy:

To get full refund, registrant must request refund five (5) days prior to live event. If less than five (5) days, registrant is transferred to product.

System requirements:

Webinar access is compatible with any Windows 7 or later computer, Android OS devices, or Apple/iOS devices. Check system compatibility here.

Accessibility for hearing impaired:

AIPLA’s webinars are available and accessible to individuals who are hearing impaired. If anyone at your location would like to know more about accommodations, please contact cle@aipla.org. We ask that you let us know at least 7 business days out from the webinar, to ensure that we can identify and deploy the solution that best fits our registrants needs.

CLE INFORMATION

CLE is approved with the following states:

Alaska
California
Missouri
New Jersey (Under New Jersey's Reciprocity Rule)
New York (Under New York's Approved Jurisdiction Policy)
Pennsylvania
Texas
Vermont

AIPLA has applied for CLE accreditation in the following states:

Illinois
Minnesota
Ohio
Tennessee
Virginia
Washington

For information on CLE accreditation in all other states, please contact our CLE Department at cle@aipla.org. CLE credit may be available, but will require additional time for approval and COA delivery.

CLE Restrictions:

ATTENTION attorneys in Louisiana, Ohio, Pennsylvania, and Utah

These states mandate attorneys can only view a webinar independently at their own computer to receive CLE credit. Multiple attendees prohibited.

ATTENTION attorneys in Alabama and Rhode Island

AIPLA does not submit courses for approval in Alabama or Rhode Island. Attendees needing credit in these states may select the free, no CLE option to watch the webinar and use course materials and their certificate of attendance to request course approval directly from the State Bars.

ATTENTION attorneys in Arizona

Arizona does not certify courses or providers. Arizona lawyers are required to independently review AZ's regulations and make their own determination that it qualifies for credit towards their MCLE requirements. MCLE Regulation 104(A) identifies the standards to apply. AIPLA will email an attendance affidavit to registrants requesting AZ CLE credit after the webinar.

ATTENTION attorneys in New Hampshire

New Hampshire attendees must self-determine whether a program is eligible for credit, and self-report their attendance according to NH Supreme Court Rule 53. The New Hampshire Minimum Continuing Legal Education (NHMCLE) Board does not approve or accredit CLE activities for the NH Minimum CLE requirement. AIPLA will email an attendance affidavit to registrants requesting NH CLE credit after the webinar.

Disclaimer: AIPLA is a nonprofit national bar association. The sole purpose of this CLE program is to provide educational and informational content. AIPLA does not provide legal services or advice. The opinions, views and other statements expressed by contributors to this CLE program are solely those of the contributors. These opinions, views and statements of the contributors do not necessarily represent those of AIPLA and should not be construed as such.

Add to: